What does proceeds from long term lines of credit mean?

Represents the cash inflows generated from drawing down on long-term revolving credit facilities or debt instruments. This metric indicates the company's reliance on external debt financing to fund operations, capital expenditures, or strategic acquisitions. It is a key indicator of financial leverage and access to capital markets.

Mesa Laboratories MLAB Proceeds From Long Term Lines Of Credit

Proceeds From Long Term Lines Of Credit at other companies

TEC

Bio-TechneTECH

$66M—

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$63.7M+2.6%

Gross profit$31.2M-0.5%

Operating income-$664.0K+85.5%

Net income$3.6M+317%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$26.9M-1.4%

Total debt$78.7M-53.1%

Total equity$186.2M+16.5%

Total assets$427.7M-1.3%

Cash flow

See full

Operating cash flow$14.0M+10.2%

CapEx$417.0K-44.9%

Free cash flow$13.5M+13.7%

Valuation

See full

Market cap$542.27M+3.7%

Enterprise value$594.05M-10.4%

P/S2.2×0.0×

Profitability

See full

Gross margin56.8%—

Operating margin2.3%—

Net margin1.5%+0.8pp

FCF margin15.9%-1.8pp

Returns & leverage

See full

Return on equity2.2%+1.1pp

Debt / equity0.4×-0.6×

Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLongTermLinesOfCredit.

The official record: Mesa Laboratories’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's proceeds from long term lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mesa Laboratories's proceeds from long term lines of credit?: Mesa Laboratories (MLAB) reported proceeds from long term lines of credit of $97M in Q3 2025.
What does proceeds from long term lines of credit mean?: Represents the cash inflows generated from drawing down on long-term revolving credit facilities or debt instruments. This metric indicates the company's reliance on external debt financing to fund operations, capital expenditures, or strategic acquisitions. It is a key indicator of financial leverage and access to capital markets.